|
J Biol Chem, Vol. 275, Issue 5, 3693-3698, February 4, 2000
Molecular Mechanism of Decreased Glutathione Content in Human
Immunodeficiency Virus Type 1 Tat-transgenic Mice*
Jinah
Choi ,
Rui-Ming
Liu§,
Ramendra K.
Kundu¶,
Frank
Sangiorgi¶,
Weicheng
Wu ,
Robert
Maxson¶, and
Henry Jay
Forman§**
From the Department of Molecular Pharmacology and
Toxicology, University of Southern California School of Pharmacy, Los
Angeles, California 90033, the § Department of Environmental
Health Sciences, School of Public Health, University of Alabama at
Birmingham, Birmingham, Alabama 35294, the ¶ Department of
Biochemistry and Molecular Biology, University of Southern
California/Norris Hospital and Research Institute, Los Angeles,
California 90089, and the Department of Pathology, University of
Southern California School of Medicine,
Los Angeles, California 90089
Human immunodeficiency virus (HIV) progressively
depletes GSH content in humans. Although the accumulated evidence
suggests a role of decreased GSH in the pathogenesis of HIV,
significant controversy remains concerning the mechanism of GSH
depletion, especially in regard to envisioning appropriate therapeutic
strategies to help compensate for such decreased antioxidant capacity.
Tat, a transactivator encoded by HIV, is sufficient to cause GSH
depletion in vitro and is implicated in AIDS-associated
Kaposi's sarcoma and B cell lymphoma. In this study, we report a
decrease in GSH biosynthesis with Tat, using HIV-1 Tat transgenic
(Tat+) mice. A significant decline in the total intracellular GSH
content in liver and erythrocytes of Tat+ mice was accompanied by
decreased -glutamylcysteine synthetase regulatory subunit mRNA
and protein content, which resulted in an increased sensitivity of
-glutamylcysteine synthetase to feedback inhibition by GSH. Further
study revealed a significant reduction in the activity of GSH
synthetase in liver of Tat+ mice, which was linearly associated with
their GSH content. Therefore, Tat appears to decrease GSH in
vivo, at least partially, through modulation of GSH biosynthetic enzymes.
*
This work was supported by the Dolores Zohrab Liebmann
Fellowship and National Institutes of Health Grant ES05511.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Dept. of Environmental
Health Sciences, School of Public Health, University of Alabama at
Birmingham, 1665 University Blvd., Ryals 317, Birmingham, AL
35294-0022. Tel.: 205-975-8949; Fax: 205-975-6341; E-mail: hforman@uab.edu.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. R. Kline, D. J. Kleinhenz, B. Liang, S. Dikalov, D. M. Guidot, C. M. Hart, D. P. Jones, and R. L. Sutliff
Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration
Am J Physiol Heart Circ Physiol,
June 1, 2008;
294(6):
H2792 - H2804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Chinta, M. J. Kumar, M. Hsu, S. Rajagopalan, D. Kaur, A. Rane, D. G. Nicholls, J. Choi, and J. K. Andersen
Inducible Alterations of Glutathione Levels in Adult Dopaminergic Midbrain Neurons Result in Nigrostriatal Degeneration
J. Neurosci.,
December 19, 2007;
27(51):
13997 - 14006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Jacob, K. M. Porter, S. C. Elms, P.-Y. Cheng, D. P. Jones, and R. L. Sutliff
HIV-1-induced pulmonary oxidative and nitrosative stress: exacerbated response to endotoxin administration in HIV-1 transgenic mouse model
Am J Physiol Lung Cell Mol Physiol,
October 1, 2006;
291(4):
L811 - L819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lin, M J. Tucker, and M. J Rieder
Increased Adverse Drug Reactions to Antimicrobials and Anticonvulsants in Patients with HIV Infection
Ann. Pharmacother.,
September 1, 2006;
40(9):
1594 - 1601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. R. Kaleeba and E. A. Berger
Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT.
Science,
March 31, 2006;
311(5769):
1921 - 1924.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Arp, M. J. Rieder, B. Urquhart, D. Freeman, M. J. Tucker, A. Krizova, D. Lehmann, and G. A. Dekaban
Hypersensitivity of HIV-1-Infected Cells to Reactive Sulfonamide Metabolites Correlated to Expression of the HIV-1 Viral Protein Tat
J. Pharmacol. Exp. Ther.,
September 1, 2005;
314(3):
1218 - 1225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Imai, K. Nakata, K. Kawai, T. Hamano, N. Mei, H. Kasai, and T. Okamoto
Induction of OGG1 Gene Expression by HIV-1 Tat
J. Biol. Chem.,
July 22, 2005;
280(29):
26701 - 26713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. K. Avraham, S. Jiang, T.-H. Lee, O. Prakash, and S. Avraham
HIV-1 Tat-Mediated Effects on Focal Adhesion Assembly and Permeability in Brain Microvascular Endothelial Cells
J. Immunol.,
November 15, 2004;
173(10):
6228 - 6233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Qiang, J. M. Cahill, J. Liu, X. Kuang, N. Liu, V. L. Scofield, J. R. Voorhees, A. J. Reid, M. Yan, W. S. Lynn, et al.
Activation of Transcription Factor Nrf-2 and Its Downstream Targets in Response to Moloney Murine Leukemia Virus ts1-Induced Thiol Depletion and Oxidative Stress in Astrocytes
J. Virol.,
November 1, 2004;
78(21):
11926 - 11938.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Bridges, H. Hu, S. Miyauchi, U. N. Siddaramappa, M. E. Ganapathy, L. Ignatowicz, D. M. Maddox, S. B. Smith, and V. Ganapathy
Induction of Cystine-Glutamate Transporter xc- by Human Immunodeficiency Virus Type 1 Transactivator Protein Tat in Retinal Pigment Epithelium
Invest. Ophthalmol. Vis. Sci.,
September 1, 2004;
45(9):
2906 - 2914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Lin, D. Irwin, S. Kanazawa, L. Huang, J. Romeo, T. S. B. Yen, and B. M. Peterlin
Transcriptional Profiles of Latent Human Immunodeficiency Virus in Infected Individuals: Effects of Tat on the Host and Reservoir
J. Virol.,
August 1, 2003;
77(15):
8227 - 8236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. O. Kim, Y. Liu, Y. Ruan, Z. C. Xu, L. Schantz, and J. J. He
Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline
Am. J. Pathol.,
May 1, 2003;
162(5):
1693 - 1707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Lewis
Defective mitochondrial DNA replication and NRTIs: pathophysiological implications in AIDS cardiomyopathy
Am J Physiol Heart Circ Physiol,
January 1, 2003;
284(1):
H1 - H9.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yang, M. Z. Dieter, Y. Chen, H. G. Shertzer, D. W. Nebert, and T. P. Dalton
Initial Characterization of the Glutamate-Cysteine Ligase Modifier Subunit Gclm(-/-) Knockout Mouse. NOVEL MODEL SYSTEM FOR A SEVERELY COMPROMISED OXIDATIVE STRESS RESPONSE
J. Biol. Chem.,
December 13, 2002;
277(51):
49446 - 49452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yang, Y. Zeng, T. D. Lee, Y. Yang, X. Ou, L. Chen, M. Haque, R. Rippe, and S. C. Lu
Role of AP-1 in the Coordinate Induction of Rat Glutamate-cysteine Ligase and Glutathione Synthetase by tert-Butylhydroquinone
J. Biol. Chem.,
September 13, 2002;
277(38):
35232 - 35239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Raidel, C. Haase, N. R. Jansen, R. B. Russ, R. L. Sutliff, L. W. Velsor, B. J. Day, B. D. Hoit, A. M. Samarel, and W. Lewis
Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage
Am J Physiol Heart Circ Physiol,
May 1, 2002;
282(5):
H1672 - H1678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-L. Levonen, D. A. Dickinson, D. R. Moellering, R. T. Mulcahy, H. J. Forman, and V. M. Darley-Usmar
Biphasic Effects of 15-Deoxy-{Delta}12,14-Prostaglandin J2 on Glutathione Induction and Apoptosis in Human Endothelial Cells
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2001;
21(11):
1846 - 1851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Dahl and R. T. Mulcahy
Cell-Type Specific Differences in Glutamate Cysteine Ligase Transcriptional Regulation Demonstrate Independent Subunit Control
Toxicol. Sci.,
June 1, 2001;
61(2):
265 - 272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-M. Liu, Z. Borok, and H. J. Forman
4-Hydroxy-2-nonenal Increases {gamma}-Glutamylcysteine Synthetase Gene Expression in Alveolar Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
April 1, 2001;
24(4):
499 - 505.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|